iRhythm Holdings, Inc. Deferred Offering Costs
iRhythm Holdings, Inc. (IRTC) had Deferred Offering Costs of $3.70 million as of 2016-10-31, per its 10-K filed 2017-03-31.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2017-03-31
- 2016-10-31: Deferred Offering Costs $3.70M.
- 2016-09-30: Deferred Offering Costs $2.60M.
- 2015-12-31: Deferred Offering Costs $300.00K.
| Period end | Deferred Offering Costs |
|---|---|
| 2016-10-31 | $3.70M 10-K · filed 2017-03-31 |
| 2016-09-30 | $2.60M 10-Q · filed 2016-12-05 |
| 2015-12-31 | $300.00K 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |